Local Institution

Goiânia, Goiás 74823

0 studies enrolling now · 15 studies all time

What they study most

Acute Coronary Syndrome, Acute Coronary Syndromes, Chronic Hepatitis B, Colitis, Ulcerative, Crohn's Disease, Diabetes, Hepato Cellular Carcinoma (HCC), Lupus Nephritis, Rheumatoid Arthritis, Rheumatoid Arthritis (RA), Systemic Lupus Erythematosus, Ulcerative Colitis

Studies at this site

• Phase IIB Rheumatoid Arthritis Dose Ranging Study for BMS-945429 in Subjects Who Are Not Responding to Methotrexate — Completed
• Efficacy and Safety Study of Abatacept to Treat Lupus Nephritis — Stopped early
• A Study of Apixaban in Patients With Atrial Fibrillation, Not Caused by a Heart Valve Problem, Who Are at Risk for Thrombosis (Blood Clots) Due to Having Had a Recent Coronary Event, Such as a Heart Attack or a Procedure to Open the Vessels of the Heart — Completed
• Efficacy and Safety Study of BMS-986142 in Patients With Moderate to Severe Rheumatoid Arthritis — Completed
• Study of Entecavir in Patients With Chronic Hepatitis B Virus (HBV) Infection — Completed
• First Line Hepato Cellular Carcinoma (HCC) — Completed
• Phase III Acute Coronary Syndrome — Stopped early
• Methotrexate-Inadequate Response Study — Completed
• Induction and Maintenance Study of BMS-936557 Patients With Moderate to Severe Ulcerative Colitis — Completed
• A Phase 3 Study of BMS-477118 in Combination With Metformin in Subjects With Type 2 Diabetes Who Are Not Controlled With Diet and Exercise — Completed
• A Study of Abatacept in Patients With Active Ulcerative Colitis — Completed
• Efficacy and Safety Study of Abatacept to Treat Lupus Nephritis — Stopped early
• Abatacept in the Treatment and Prevention of Active Systemic Lupus Erythematosus (SLE) Flares in Combination With Prednisone — Completed
• Remission and Joint Damage Progression in Early Rheumatoid Arthritis — Completed
• A Study of Abatacept in Patients With Active Crohn's Disease — Stopped early